Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10490
Title: Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
Authors: Mulvany, Nicholas J;Allen, David G
Affiliation: Department of Anatomical Pathology, Austin Hospital, Heidelberg, Victoria, Australia. nicholas.mulvany@austin.org.au
Issue Date: 1-Jan-2008
Citation: International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists; 27(1): 49-57
Abstract: We present the surgical and pathological findings and follow-up of 5 women diagnosed with combined endometrioid and high-grade neuroendocrine carcinoma of large cell type (LCNEC) arising in the endometrium. The mean age of the women was 75 years (range, 50-88 years). Of the 5 tumors, 4 formed polypoid endometrial masses associated with extensive lymphovascular involvement of the myometrium by neoplastic cells. A single endometrial tumor was formed by LCNEC alone, and 4 tumors were composite with varying proportions formed by endometrioid (4/5) and small cell neuroendocrine carcinoma (1/5). In all 5 LCNEC tumor components, an insular growth pattern was noted, whereas a diffuse (solid) pattern was found in 4 tumors, a trabecular in 2, and rosettes/pseudorosettes in another 2. In all 5 tumors, the LCNEC tumor components were labeled with neuron-specific enolase (NSE). Four tumors were reactive for chromogranin A, CAM 5.2, and p53. Three tumors were labeled for AE1/AE3, CD56 (NCAM), p16, and cytokeratin 7. Synaptophysin was reactive in 2 tumors, and CD117 was found in only a single tumor. Of the 3 endometrioid tumor components examined, all were reactive for NSE. Two tumors were reactive for p16 and p53, 1 for CD56, but none for synaptophysin orchromogranin A. We conclude that LCNEC of the endometrium is a distinct clinicopathological entity with a poor prognosis irrespective of stage. The gross and histomorphological features are often suggestive, but confirmation requires immunoperoxidases, including NSE, synaptophysin, chromogranin A, p16, and p53. Combined endometrioid and high-grade LCNEC possess more characteristics of a type II than a type I endometrial carcinoma.
Internal ID Number: 18156975
URI: http://ahro.austin.org.au/austinjspui/handle/1/10490
DOI: 10.1097/pgp.0b013e31806219c5
URL: http://www.ncbi.nlm.nih.gov/pubmed/18156975
Type: Journal Article
Subjects: Aged
Aged, 80 and over
Carcinoma, Endometrioid.metabolism.pathology
Carcinoma, Large Cell.metabolism.pathology
Carcinoma, Neuroendocrine.metabolism.pathology
Endometrial Neoplasms.metabolism.pathology
Female
Humans
Immunohistochemistry
Middle Aged
Tumor Markers, Biological.analysis
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.